logo

For the Inventor, By the Inventor

Mannheim, Germany

Matthias Eder

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 7.0

ph-index = 4

Forward Citations = 50(Granted Patents)


Location History:

  • Simonswald, DE (2022 - 2023)
  • Mannheim, DE (2018 - 2024)
  • Freiburg, DE (2020 - 2024)

Company Filing History:

goldMedal11 out of 155 
 
Deutsches Krebsforschungszentrum
 patents
silverMedal4 out of 63 
 
Ruprecht-karls-universitat Heidelberg
 patents
bronzeMedal4 out of 23 
 
Ruprecht-karls-universitaet Heidelberg
 patents
4. 2 out of 3,923 
 
Novartis Ag
 patents
where one patent can have more than one assignee

Years Active: 2018-2024

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 12156920 - Double-labeled probe for molecular imaging and use thereof (2024-12-03),
2. 12054458 - F-tagged inhibitors of prostate specific membrane antigen (PSMA) and their use as imaging agents for prostate cancer (2024-08-06),
3. 11951190 - Use of labeled inhibitors of prostate specific membrane antigen (PSMA), as agents for the treatment of prostate cancer (2024-04-09),
4. 11931430 - Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the treatment of prostate cancer (2024-03-19),
5. 11638765 - Double-labeled probe for molecular imaging and use thereof (2023-05-02),
6. 11452786 - Double-labeled probe for molecular imaging and use thereof (2022-09-27),
7. 11045564 - Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the treatment of prostate cancer (2021-06-29),
8. 11020493 - Double-labeled probe for molecular imaging and use thereof (2021-06-01),
9. 10815200 - 18F—tagged inhibitors of prostate specific membrane antigen (PSMA) and their use as imaging agents for prostate cancer (2020-10-27),
10. 10471160 - Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer (2019-11-12),
11. 10406246 - Double-labeled probe for molecular imaging and use thereof (2019-09-10),
12. 10398791 - Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer (2019-09-03),
13. 10016519 - 18F-tagged inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer (2018-07-10),

Title: The Innovative Mind of Matthias Eder

Introduction: Matthias Eder, a pioneering inventor hailing from Mannheim, Germany, has made significant contributions to the world of innovations with his creative and forward-thinking approach.

Latest Patents: Matthias Eder's latest patents showcase his expertise in various fields, including technology, engineering, and design. His recent inventions have been recognized for their ingenuity and practicality in solving complex problems.

Career Highlights: Throughout his illustrious career, Matthias Eder has demonstrated a remarkable ability to transform ideas into tangible inventions. His passion for innovation has led to the development of groundbreaking technologies that have had a lasting impact on industries worldwide.

Collaborations: Matthias Eder has collaborated with leading companies, research institutions, and universities to further his innovative projects. His ability to work effectively in multidisciplinary teams has been instrumental in bringing his ideas to life and pushing the boundaries of what is possible.

Conclusion: In conclusion, Matthias Eder stands as a shining example of an inventor whose relentless pursuit of innovation has reshaped the technological landscape. His dedication to pushing the boundaries of what is possible serves as an inspiration to aspiring inventors and innovators around the globe.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…